7 Matching Annotations
  1. Aug 2025
  2. www.biorxiv.org www.biorxiv.org
    Using targeted therapy to promote a pro-inflammatory tumour microenvironment and anti-tumour immune response in high grade serous ovarian cancer
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    biorxiv.org/content/10.1101/2025.08.10.669554v1
  3. Jul 2025
  4. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune Activation
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC11543919/
  5. Feb 2025
  6. aacrjournals.org aacrjournals.org
    YAP1 suppression by ZDHHC7 is associated with ferroptosis resistance and poor prognosis in ovarian clear cell carcinoma
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    aacrjournals.org/mct/article/23/11/1652/749309/YAP1-Suppression-by-ZDHHC7-Is-Associated-with
  7. Nov 2024
  8. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    A novel ITGB8 transcript variant sustains ovarian cancer cell survival through genomic instability and altered ploidy on a mutant p53 background
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC11539462/
  9. Jul 2023
  10. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    ATF6-mediated signaling contributes to PARP Inhibitor Resistance in Ovarian Cancer
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9812934/
  11. Mar 2023
  12. www.mdpi.com www.mdpi.com
    A NOTCH1 Mutation Found in a Newly Established Ovarian Cancer Cell Line (FDOVL) Promotes Lymph Node Metastasis in Ovarian Cancer
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    mdpi.com/1422-0067/24/6/5091
  13. www.biorxiv.org www.biorxiv.org
    Combinatory EHMT and PARP inhibition induces an interferon response and a CD8 T cell-dependent tumor regression in PARP inhibitor-resistant models
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    biorxiv.org/content/10.1101/2023.02.23.529773v1